Share-based Payment Arrangement, Expense of AEON Biopharma, Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AEON Biopharma, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • AEON Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,000,000, a 38% decline year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

AEON Biopharma, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,000,000 -$600,000 -38% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,600,000 -$100,000 -5.9% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,700,000 +$100,000 +6.2% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 $1,600,000 -$600,000 -27% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $1,700,000 +$1,000,000 +143% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $1,600,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q3 2023 $2,200,000 22 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $700,000 01 Jul 2023 21 Jul 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $1,100,000 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.